New Two-Drug attack on cancer shows promise in early testing

NCT ID NCT05516914

Summary

This study is testing whether combining two immunotherapy drugs—LBL-007 and tislelizumab—is safe and effective for treating various cancers. Researchers will enroll up to 490 adults with solid tumors to determine the best dose and see how well the combination shrinks tumors. The trial is currently recruiting participants across multiple medical centers.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Anhui Cancer Hospital

    RECRUITING

    Hefei, Anhui, 230031, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Central People's Hospital of Zhanjinag

    NOT_YET_RECRUITING

    Zhanjiang, Guangdong, 524000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, Shanghai Municipality, 201100, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fujian Cancer Hospital

    RECRUITING

    Fuzhou, Fujian, 350001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Guangxi Tumour Hospital

    RECRUITING

    Nanning, Guangxi, 530000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hubei Cancer Hospital

    RECRUITING

    Wuhan, Hubei, 430000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Huizhou Municipal Central Hospital

    RECRUITING

    Huizhou, Guangdong, 516000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hunan Cancer Hospital

    RECRUITING

    Changsha, Hunan, 410000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Jiangxi Cancer Hospital

    RECRUITING

    Nanchang, Jiangxi, 330029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Maoming People's Hospital

    NOT_YET_RECRUITING

    Maoming, Guangdong, 525000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University

    RECRUITING

    Guangzhou, Guangdong, 510120, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 510060, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Guangxi Medical University

    RECRUITING

    Nanning, Guangxi, 530021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First People's Hospital of Yu Lin

    RECRUITING

    Yulin, Guangxi, 537000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Jiangmen Central Hospital

    RECRUITING

    Jiangmen, Guangdong, 440700, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Second Affiliated Hospital of Hainan Medical University

    RECRUITING

    Haikou, Hainan, 570000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Union Hospital Tongji Medical College Huazhong University of Science And Technology

    RECRUITING

    Wuhan, Hubei, 430022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • West China Hospital of Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhejiang Cancer Hospital

    RECRUITING

    Hangzhou, Hangzhou, 310000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.